Effects of ibopamine on the increase in plasma norepinephrine levels during exercise in congestive heart failure.
暂无分享,去创建一个
D. V. van Veldhuisen | K. Lie | W. V. van Gilst | P. D. de Graeff | A. Girbes | S. V. D. van den Broek
[1] M. Packer. The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failure. , 1992, Journal of the American College of Cardiology.
[2] W. Reitsma,et al. Effects of Ibopamine on Exercise-Induced Increase in Norepinephrine in Normal Men , 1992, Journal of cardiovascular pharmacology.
[3] M. Mannelli,et al. Endogenous dopamine (DA) and DA2 receptors: a mechanism limiting excessive sympathetic-adrenal discharge in humans. , 1988, The Journal of clinical endocrinology and metabolism.
[4] T. Karrison,et al. Effects of long-term therapy with oral ibopamine on resting hemodynamics and exercise capacity in patients with heart failure: relationship to the generation of N-methyldopamine and to plasma norepinephrine levels. , 1986, Circulation.
[5] C. Johnston,et al. Controlled trial of enalapril in congestive cardiac failure. , 1985, British heart journal.
[6] J. Cohn,et al. Response of plasma norepinephrine and epinephrine to dynamic exercise in patients with congestive heart failure. , 1982, The American journal of cardiology.